Thalamocortical development: how are we going to get there?

Before We Get There, Where Are We Going?

Fictional stories abound where artificial intelligence gives rise to manmade servants that make our lives a holiday (or a nightmare). Naturally, the optimist has a strong motive to ask: How might we design and implement an artificial servant? We regularly operate under the notion that one agent helps another by doing something for the other. However, the story behind this is much more complicat...

GEC into the future: Where are we going and how do we get there?

The field of grammatical error correction (GEC) has made tremendous bounds in the last ten years, but new questions and obstacles are revealing themselves. In this position paper, we discuss the issues that need to be addressed and provide recommendations for the field to continue to make progress, and propose a new shared task. We invite suggestions and critiques from the audience to make the ...

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Improved supportive care, more precise risk stratification, and personalized chemotherapy based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and pharmacogenetics) have pushed the cure rate of childhood acute lymphoblastic leukemia to near 90%. Further increase in cure rate can be expected from the discovery of additional recurrent molecular lesions, coupled with the ...

Perspectives Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Improved supportive care, more precise risk stratification, and personalized chemotherapy based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and pharmacogenetics) have pushed the cure rate of childhood acute lymphoblastic leukemia to near 90%. Further increase in cure rate can be expected from the discovery of additional recurrent molecular lesions, coupled with the ...

How did we get here and where are we going?